Patents by Inventor DAVID H. HITT, III

DAVID H. HITT, III has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • TRANS-RESVERATROL TOPICAL MEDICATION FOR THE TREATMENT OF PAIN AND METHOD OF MANUFACTURE THEREOF
    Publication number: 20220000798
    Abstract: The invention provides a topical pain medication and a method of manufacturing and suing the same. In one embodiment, the medication includes: (1) enriched resveratrol having a concentration of trans-resveratrol therein that substantially exceeds the natural concentrations of trans-resveratrol in naturally occurring resveratrol, and (2) at least one inactive ingredient configured to mix with the resveratrol to form the topical medication. In one embodiment, the method includes: (1) processing resveratrol to increase the concentration of trans-resveratrol therein and (2) mixing at least one inactive ingredient with the resveratrol to form the topical medication.
    Type: Application
    Filed: July 13, 2021
    Publication date: January 6, 2022
    Inventors: Dennis I. Robbins, David H. Hitt, JR., David H. Hitt, III
  • Trans-resveratrol topical medication for the treatment of pain and method of manufacture thereof
    Patent number: 11103465
    Abstract: The invention provides a topical pain medication and a method of manufacturing and suing the same. In one embodiment, the medication includes: (1) enriched resveratrol having a concentration of trans-resveratrol therein that substantially exceeds the natural concentrations of trans-resveratrol in naturally occurring resveratrol, and (2) at least one inactive ingredient configured to mix with the resveratrol to form the topical medication. In one embodiment, the method includes: (1) processing resveratrol to increase the concentration of trans-resveratrol therein and (2) mixing at least one inactive ingredient with the resveratrol to form the topical medication.
    Type: Grant
    Filed: August 27, 2018
    Date of Patent: August 31, 2021
    Assignee: Ted's Brain Science, Inc.
    Inventors: Dennis I. Robbins, David H. Hitt, Jr., David H. Hitt, III
  • RESVERATROL MEDICATION FOR THE TREATMENT OF OCULAR PAIN AND METHOD OF USE THEREOF
    Publication number: 20210046018
    Abstract: The present disclosure provides ophthalmic compositions containing resveratrol. Also provided are methods of using ophthalmic resveratrol compositions to treat acute ocular pain, chronic ocular pain, dry eye disease, and/or photophobia.
    Type: Application
    Filed: August 13, 2020
    Publication date: February 18, 2021
    Applicants: TED'S BRAIN SCIENCE, INC., BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM, OREGON HEALTH AND SCIENCE UNIVERSITY
    Inventors: SUE A. AICHER, GREGORY O. DUSSOR, THEODORE J. PRICE, DENNIS I. ROBBINS, DAVID H. HITT, II, DAVID H. HITT, III
  • TRANS-RESVERATROL TOPICAL MEDICATION FOR THE TREATMENT OF PAIN AND METHOD OF MANUFACTURE THEREOF
    Publication number: 20190151254
    Abstract: The invention provides a topical pain medication and a method of manufacturing and suing the same. In one embodiment, the medication includes: (1) enriched resveratrol having a concentration of trans-resveratrol therein that substantially exceeds the natural concentrations of trans-resveratrol in naturally occurring resveratrol, and (2) at least one inactive ingredient configured to mix with the resveratrol to form the topical medication. In one embodiment, the method includes: (1) processing resveratrol to increase the concentration of trans-resveratrol therein and (2) mixing at least one inactive ingredient with the resveratrol to form the topical medication.
    Type: Application
    Filed: August 27, 2018
    Publication date: May 23, 2019
    Inventors: DENNIS I. ROBBINS, DAVID H. HITT, JR., DAVID H. HITT, III